Original Research
Published on 17 Feb 2026
Identification of predictive biomarkers and dose optimization for camrelizumab combined with apatinib in the treatment of advanced hepatocellular carcinoma: a quantitative systems pharmacology approach
in Systems Immunology
- 178 views